A detailed history of Parsons Capital Management Inc transactions in Organon & Co. stock. As of the latest transaction made, Parsons Capital Management Inc holds 11,473 shares of OGN stock, worth $254,585. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,473
Previous 12,038 4.69%
Holding current value
$254,585
Previous $226,000 4.87%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$17.45 - $21.96 $9,859 - $12,407
-565 Reduced 4.69%
11,473 $237,000
Q1 2024

Apr 22, 2024

SELL
$13.78 - $18.8 $3,486 - $4,756
-253 Reduced 2.06%
12,038 $226,000
Q4 2023

Jan 22, 2024

SELL
$10.95 - $17.32 $18,757 - $29,669
-1,713 Reduced 12.23%
12,291 $177,000
Q3 2023

Nov 06, 2023

SELL
$16.59 - $23.77 $4,164 - $5,966
-251 Reduced 1.76%
14,004 $243,000
Q2 2023

Aug 04, 2023

SELL
$19.27 - $24.63 $26,130 - $33,398
-1,356 Reduced 8.69%
14,255 $296,000
Q1 2023

Apr 17, 2023

SELL
$21.42 - $32.08 $4,412 - $6,608
-206 Reduced 1.3%
15,611 $367,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $374,381 - $459,505
-16,061 Reduced 50.38%
15,817 $441,000
Q3 2022

Oct 26, 2022

SELL
$23.4 - $34.25 $125,681 - $183,956
-5,371 Reduced 14.42%
31,878 $746,000
Q2 2022

Jul 29, 2022

SELL
$31.66 - $38.9 $333,253 - $409,461
-10,526 Reduced 22.03%
37,249 $1.26 Million
Q1 2022

May 02, 2022

SELL
$30.45 - $39.36 $13,763 - $17,790
-452 Reduced 0.94%
47,775 $1.67 Million
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $55,017 - $71,252
-1,919 Reduced 3.83%
48,227 $1.47 Million
Q3 2021

Nov 09, 2021

BUY
$28.63 - $35.64 $11,509 - $14,327
402 Added 0.81%
50,146 $1.64 Million
Q2 2021

Aug 03, 2021

BUY
$28.45 - $38.0 $1.42 Million - $1.89 Million
49,744 New
49,744 $1.51 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.64B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.